Orbimed Advisors - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 112 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$10,965,000
+101.6%
521,891
+86.7%
0.20%
+106.1%
Q2 2022$5,439,000
+814.1%
279,500
+935.2%
0.10%
+890.0%
Q1 2022$595,000
-66.0%
27,000
-62.1%
0.01%
-60.0%
Q4 2019$1,748,00071,3000.02%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,921,118$37,385,00054.94%
Frazier Life Sciences Management, L.P. 3,566,912$69,412,0006.55%
NEA Management Company, LLC 4,187,801$81,495,0004.19%
Highlander Partners, L.P. 122,980$2,393,0003.15%
Prosight Management, LP 161,527$3,143,0002.48%
Novo Holdings A/S 2,027,324$37,931,0001.87%
CADIAN CAPITAL MANAGEMENT, LP 1,385,997$26,972,0001.82%
MPM BioImpact LLC 288,531$5,615,0001.56%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,244,434$63,137,0001.30%
Rock Springs Capital Management LP 1,717,733$33,427,0000.97%
View complete list of MIRUM PHARMACEUTICALS INC shareholders